95 related articles for article (PubMed ID: 7229618)
1. Analysis of the origin of charge heterogeneity of Rauscher murine leukaemia virus p30.
Brouwer J; Warnaar SO
J Gen Virol; 1980 Dec; 51(Pt 2):409-14. PubMed ID: 7229618
[TBL] [Abstract][Full Text] [Related]
2. Murine leukaemia virus p30 heterogeneity as revealed by two-dimensional gel electrophoresis is not an artefact of the technique.
Katoh I; Yoshinaka Y; Luftig RB
J Gen Virol; 1984 Apr; 65 ( Pt 4)():733-41. PubMed ID: 6323621
[TBL] [Abstract][Full Text] [Related]
3. Chemical characterization of Rauscher leukaemia virus proteins.
Brouwer J; Pluijms WJ; Warnaar SO
J Gen Virol; 1979 Feb; 42(2):415-21. PubMed ID: 422956
[TBL] [Abstract][Full Text] [Related]
4. The structural relatedness of the virus core proteins of Rauscher and Moloney murine leukaemia virus.
Ng VL; Kopchick JJ; Karshin WL; Wood TG; Arlinghaus RB
J Gen Virol; 1980 Mar; 47(1):161-70. PubMed ID: 7365462
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of the in vitro products generated by proteolytic cleavage of Gazdar murine sarcoma virus p65gag.
Maxwell SA; Arlinghaus RB
J Gen Virol; 1985 Jan; 66 ( Pt 1)():97-107. PubMed ID: 2981963
[TBL] [Abstract][Full Text] [Related]
6. Effect of interferon on mouse leukaemia virus (MuLV). V. Abnormal proteins in virions of Rauscher MuLV produced in the presence of interferon.
Pitha PM; Fernie B; Maldarelli F; Hattman T; Wivel NA
J Gen Virol; 1980 Jan; 46(1):97-110. PubMed ID: 7351537
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of Rauscher leukaemia virus (R-MuLV) Pr65gag by the Moloney leukaemia virus (M-MuLV) proteolytic activity produces the R-MuLV-specific but not the M-MuLV-specific 40 000 dalton intermediate polypeptide.
Yoshinaka Y; Luftig RB
J Gen Virol; 1981 May; 54(Pt 1):33-8. PubMed ID: 7288407
[TBL] [Abstract][Full Text] [Related]
8. Tryptic peptide analyses of polypeptides generated by premature termination of cell-free protein synthesis allow a determination of the Rauscher leukemia virus gag gene order.
Murphy EC; Arlinghaus RB
J Virol; 1978 Dec; 28(3):929-35. PubMed ID: 731799
[TBL] [Abstract][Full Text] [Related]
9. Natural antibodies in human sera cross-reactive with type C RNA tumor viral P 30.
Herbrink P; van Bussel FJ; Warnaar SO
Anticancer Res; 1982; 2(5):291-6. PubMed ID: 6299171
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a p30 fraction from Rauscher leukemia virus which has an associated ATPase activity.
Meric AL; Purtell MJ; Levy CC
J Biol Chem; 1984 Oct; 259(20):12865-72. PubMed ID: 6208191
[TBL] [Abstract][Full Text] [Related]
11. Quantitative immunoelectrophoretic assay for murine oncornavirus p30: noncovalent facilitation by sodium dodecyl sulfate.
Robinson OR; Shibley GP; Sevoian M
Infect Immun; 1977 Oct; 18(1):60-7. PubMed ID: 908622
[TBL] [Abstract][Full Text] [Related]
12. Differences in the pI heterogeneity of virion and intracellular Moloney murine leukaemia virus p30s.
Ikuta K; Luftig RB
J Gen Virol; 1987 Feb; 68 ( Pt 2)():487-98. PubMed ID: 3493325
[TBL] [Abstract][Full Text] [Related]
13. Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism.
Gautsch JW; Elder JH; Schindler J; Jensen FC; Lerner RA
Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4170-4. PubMed ID: 212738
[TBL] [Abstract][Full Text] [Related]
14. Proteins of Rauscher murine leukemia virus: resolution of a 70,000-dalton, Nonglycosylated polypeptide containing p30 peptide sequences.
Jamjoom G; Karshin WL; Naso RB; Arcement LJ; Arlinghaus RB
Virology; 1975 Nov; 68(1):135-45. PubMed ID: 1189292
[No Abstract] [Full Text] [Related]
15. Immunological characterization of a low molecular weight polypeptide of murine leukemia virus.
Tronick SR; Stephenson JR; Aaronson SA
Virology; 1973 Jul; 54(1):199-206. PubMed ID: 4351609
[No Abstract] [Full Text] [Related]
16. In vitro cleavage of Pr65gag by the Moloney murine leukaemia virus proteolytic activity yields p30 whose NH2-terminal sequence is identical to virion p30.
Yoshinaka Y; Shames RB; Luftig RB; Smythers GW; Oroszlan S
J Gen Virol; 1985 Feb; 66 ( Pt 2)():379-83. PubMed ID: 2578553
[TBL] [Abstract][Full Text] [Related]
17. Recombinants between temperature-sensitive mutants of rauscher murine leukemia virus and BALB:virus-2: genetic mapping of the Rauscher murine leukemia virus genome.
Merregaert J; Barbacid M; Aaronson SA
J Virol; 1981 Jul; 39(1):219-28. PubMed ID: 6268812
[TBL] [Abstract][Full Text] [Related]
18. Tryptic peptide analysis of gag and gag-pol gene products of Rauscher murine leukemia virus.
Kopchick JJ; Karshin WL; Arlinghaus RB
J Virol; 1979 May; 30(2):610-23. PubMed ID: 469995
[TBL] [Abstract][Full Text] [Related]
19. Polypeptides of feline leukaemia virus: identification of p15(E) and p12(E).
Neil JC; Onions DE; Jarrett O
J Gen Virol; 1980 Oct; 50(2):455-60. PubMed ID: 6257828
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the major viral polypeptide in cells transformed by wild-type and temperature-sensitive murine sarcoma virus.
Spira G; Dreesman GR; Benyesh-Melnick M; Kit S; Somers KD
Intervirology; 1974; 4(2):99-109. PubMed ID: 4141344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
